Home › Funds › Two Sigma Investments › QNCX
Two Sigma Investments position in QNCX
QUINCE THERAPEUTICS INC · Health Care
Latest position (Q1 2026)71.22K sh
Reported value held$7.22K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 73.08K | $6.70M | New |
| Q4 2021 | 597.48K | $7.54M | Add |
| Q1 2022 | 476.28K | $2.95M | Reduce |
| Q2 2022 | 510.35K | $1.13M | Add |
| Q3 2022 | 497.53K | $662.00K | Reduce |
| Q4 2022 | 467.28K | $297.85K | Reduce |
| Q1 2023 | 127.09K | $198.25K | Reduce |
| Q2 2023 | 69.53K | $104.64K | Reduce |
| Q3 2023 | 19.64K | $22.00K | Reduce |
| Q4 2023 | 13.18K | $13.84K | Reduce |
| Q4 2024 | 30.34K | $56.74K | New |
| Q1 2025 | 41.15K | $54.73K | Add |
| Q1 2025 | 41.15K | $54.73K | Add |
| Q2 2025 | 17.39K | $28.69K | Reduce |
| Q2 2025 | 17.39K | $28.69K | Reduce |
| Q3 2025 | 15.08K | $24.58K | Reduce |
| Q4 2025 | 180.95K | $606.18K | Add |
| Q1 2026 | 71.22K | $7.22K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding QNCX
- Balyasny Asset Management 69.97K sh · $12.56M · Q2 2026
- Vanguard Group 2.08M sh · $6.98M · Q4 2025
- Millennium Management 70.78K sh · $1.29M · Q2 2026
- UBS Group AG 4.73K sh · $86.04K · Q2 2026
- Morgan Stanley 4.08K sh · $74.29K · Q2 2026
- BlackRock Inc 1.70K sh · $30.96K · Q2 2026
- Wells Fargo & Co 10 sh · $182 · Q2 2026
- JPMorgan Chase & Co 2 sh · $2 · Q2 2026